These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 38890647

  • 1. Genetic characteristics of chromosomally integrated carbapenemase gene (blaNDM-1) in isolates of Proteus mirabilis.
    Wang Q, Dong K, Liu X, Li W, Bian Q.
    BMC Microbiol; 2024 Jun 19; 24(1):216. PubMed ID: 38890647
    [Abstract] [Full Text] [Related]

  • 2. First report of blaOXA-24 carbapenemase gene, armA methyltransferase and aac(6')-Ib-cr among multidrug-resistant clinical isolates of Proteus mirabilis in Algeria.
    Leulmi Z, Kandouli C, Mihoubi I, Benlabed K, Lezzar A, Rolain JM.
    J Glob Antimicrob Resist; 2019 Mar 19; 16():125-129. PubMed ID: 30217548
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Study of the molecular characteristics and homology of carbapenem-resistant Proteus mirabilis by whole genome sequencing.
    Liu M, Li D, Jia W, Ma J, Zhao X.
    J Med Microbiol; 2023 Jan 19; 72(1):. PubMed ID: 36748625
    [Abstract] [Full Text] [Related]

  • 5. Genomic characterisation of a Proteus mirabilis clinical isolate from China carrying blaNDM-5 on an IncX3 plasmid.
    Sun L, Xu J, He F.
    J Glob Antimicrob Resist; 2019 Dec 19; 19():317-319. PubMed ID: 31698108
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genomic profiling of pan-drug resistant proteus mirabilis Isolates reveals antimicrobial resistance and virulence gene landscape.
    Soliman S, Abdalla S, Zedan A, Enany S.
    Funct Integr Genomics; 2024 Sep 03; 24(5):154. PubMed ID: 39223360
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Molecular drivers of emerging multidrug resistance in Proteus mirabilis clinical isolates from Algeria.
    Boudjemaa H, Allem R, Fonkou MDM, Zouagui S, Khennouchi NCEH, Kerkoud M.
    J Glob Antimicrob Resist; 2019 Sep 03; 18():249-256. PubMed ID: 30797091
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Emergence of extensive drug resistance and high prevalence of multidrug resistance among clinical Proteus mirabilis isolates in Egypt.
    ElTaweel M, Said HS, Barwa R.
    Ann Clin Microbiol Antimicrob; 2024 May 24; 23(1):46. PubMed ID: 38790053
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Survey of multidrug resistance integrative mobilizable elements SGI1 and PGI1 in Proteus mirabilis in humans and dogs in France, 2010-13.
    Schultz E, Haenni M, Mereghetti L, Siebor E, Neuwirth C, Madec JY, Cloeckaert A, Doublet B.
    J Antimicrob Chemother; 2015 Sep 24; 70(9):2543-6. PubMed ID: 26066582
    [Abstract] [Full Text] [Related]

  • 19. Unveiling the genetic architecture and transmission dynamics of a novel multidrug-resistant plasmid harboring blaNDM-5 in E. Coli ST167: implications for antibiotic resistance management.
    Han D, Ma S, He C, Yang Y, Li P, Lu L.
    BMC Microbiol; 2024 May 23; 24(1):178. PubMed ID: 38783210
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.